Enhancing Diversity and Quality in Medical Research: The Power of Decentralized Clinical Trials
The Transformative Power of Clinical Trial Referrals in Non-Academic Practices
.png)
The Transformative Power of Clinical Trial Referrals in Non-Academic Practices "Alone, we can do so little; together, we can do so much." - Helen Keller In the rapidly evolving healthcare landscape, the referral of patients from non-academic medical practices to clinical trials emerges as a potent collaborative strategy. The benefits of this referral mechanism ripple beyond individual interactions, impacting all stakeholders positively – the referring physician, the patient, and the Principal Investigator (P.I.) and Sub-Investigator (Sub I). Organizations facilitating this process and the pharmaceutical companies sponsoring these trials play instrumental roles in this ecosystem. For the Referring Physician and Patients Referring patients to clinical trials brings many advantages to physicians outside academic medical centers. It allows them to provide their patients' access to potentially groundbreaking treatments and a unique opportunity to stay updated with the latest
.png)
.png)
Comments
Post a Comment